OXT and schizophrenia: Early suggestions of OXT as a `natural antipsychotic’ and evidence from animal studies demonstrating OXT to counteract excessive mesolimbic dopamine and cortical hypoglutamatergia led to the assumption that OXT signaling might be altered in schizophrenia (Macdonald and Feifel, 2012).